Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Standard BioTools Inc. (NASDAQ: LAB)
LAB Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
7.70%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
-40.80%
LAB Stock Analysis
LAB
PE Ratio:
5.7
LAB
PEG Ratio:
Not Available
LAB
Forward EPS Growth (12 month):
0.00%
LAB
PS Ratio:
5.2
LAB
PSG Ratio:
2.7
LAB
Forward Revenue Growth (12 month):
1.90%
LAB Articles
No data was found